Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2012

Open Access 01-12-2012 | Research article

Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons

Authors: Fujian Song, Allan Clark, Max O Bachmann, Jim Maas

Published in: BMC Medical Research Methodology | Issue 1/2012

Login to get access

Abstract

Background

Indirect treatment comparison (ITC) and mixed treatment comparisons (MTC) have been increasingly used in network meta-analyses. This simulation study comprehensively investigated statistical properties and performances of commonly used ITC and MTC methods, including simple ITC (the Bucher method), frequentist and Bayesian MTC methods.

Methods

A simple network of three sets of two-arm trials with a closed loop was simulated. Different simulation scenarios were based on different number of trials, assumed treatment effects, extent of heterogeneity, bias and inconsistency. The performance of the ITC and MTC methods was measured by the type I error, statistical power, observed bias and mean squared error (MSE).

Results

When there are no biases in primary studies, all ITC and MTC methods investigated are on average unbiased. Depending on the extent and direction of biases in different sets of studies, ITC and MTC methods may be more or less biased than direct treatment comparisons (DTC). Of the methods investigated, the simple ITC method has the largest mean squared error (MSE). The DTC is superior to the ITC in terms of statistical power and MSE. Under the simulated circumstances in which there are no systematic biases and inconsistencies, the performances of MTC methods are generally better than the performance of the corresponding DTC methods. For inconsistency detection in network meta-analysis, the methods evaluated are on average unbiased. The statistical power of commonly used methods for detecting inconsistency is very low.

Conclusions

The available methods for indirect and mixed treatment comparisons have different advantages and limitations, depending on whether data analysed satisfies underlying assumptions. To choose the most valid statistical methods for research synthesis, an appropriate assessment of primary studies included in evidence network is required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ: Indirect comparisons of competing interventions. Health Technol Assess. 2005, 9 (26): 1-134. iii-ivCrossRefPubMed Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ: Indirect comparisons of competing interventions. Health Technol Assess. 2005, 9 (26): 1-134. iii-ivCrossRefPubMed
2.
go back to reference Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG: Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: a survey of published systematic reviews. BMJ. 2009, 338: b1147-10.113/bmj.b1147.CrossRefPubMedPubMedCentral Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG: Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: a survey of published systematic reviews. BMJ. 2009, 338: b1147-10.113/bmj.b1147.CrossRefPubMedPubMedCentral
3.
go back to reference Donegan S, Williamson P, Gamble C, Tudur-Smith C: Indirect comparisons: a review of reporting and methodological quality. PLoS One. 2010, 5 (11): e11054-10.1371/journal.pone.0011054.CrossRefPubMedPubMedCentral Donegan S, Williamson P, Gamble C, Tudur-Smith C: Indirect comparisons: a review of reporting and methodological quality. PLoS One. 2010, 5 (11): e11054-10.1371/journal.pone.0011054.CrossRefPubMedPubMedCentral
4.
go back to reference Edwards SJ, Clarke MJ, Wordsworth S, Borrill J: Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Int J Clin Pract. 2009, 63 (6): 841-854. 10.1111/j.1742-1241.2009.02072.x.CrossRefPubMed Edwards SJ, Clarke MJ, Wordsworth S, Borrill J: Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Int J Clin Pract. 2009, 63 (6): 841-854. 10.1111/j.1742-1241.2009.02072.x.CrossRefPubMed
5.
go back to reference Bucher HC, Guyatt GH, Griffith LE, Walter SD: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997, 50 (6): 683-691. 10.1016/S0895-4356(97)00049-8.CrossRefPubMed Bucher HC, Guyatt GH, Griffith LE, Walter SD: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997, 50 (6): 683-691. 10.1016/S0895-4356(97)00049-8.CrossRefPubMed
6.
go back to reference Higgins JP, Whitehead A: Borrowing strength from external trials in a meta-analysis. Stat Med. 1996, 15 (24): 2733-2749. 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0.CrossRefPubMed Higgins JP, Whitehead A: Borrowing strength from external trials in a meta-analysis. Stat Med. 1996, 15 (24): 2733-2749. 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0.CrossRefPubMed
7.
go back to reference Lumley T: Network meta-analysis for indirect treatment comparisons. Stat Med. 2002, 21 (16): 2313-2324. 10.1002/sim.1201.CrossRefPubMed Lumley T: Network meta-analysis for indirect treatment comparisons. Stat Med. 2002, 21 (16): 2313-2324. 10.1002/sim.1201.CrossRefPubMed
8.
go back to reference Lu G, Ades AE: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23 (20): 3105-3124. 10.1002/sim.1875.CrossRefPubMed Lu G, Ades AE: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23 (20): 3105-3124. 10.1002/sim.1875.CrossRefPubMed
9.
go back to reference Lu G, Ades AE: Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc. 2006, 101 (474): 447-459. 10.1198/016214505000001302.CrossRef Lu G, Ades AE: Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc. 2006, 101 (474): 447-459. 10.1198/016214505000001302.CrossRef
10.
go back to reference Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC: Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011, 14 (4): 417-428. 10.1016/j.jval.2011.04.002.CrossRefPubMed Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC: Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011, 14 (4): 417-428. 10.1016/j.jval.2011.04.002.CrossRefPubMed
11.
go back to reference Jansen JP, Schmid CH, Salanti G: Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons. J Clin Epidemiol. 2012, 65 (7): 798-807. 10.1016/j.jclinepi.2012.01.002.CrossRefPubMed Jansen JP, Schmid CH, Salanti G: Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons. J Clin Epidemiol. 2012, 65 (7): 798-807. 10.1016/j.jclinepi.2012.01.002.CrossRefPubMed
12.
go back to reference Song F, Altman DG, Glenny AM, Deeks JJ: Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003, 326 (7387): 472-475. 10.1136/bmj.326.7387.472.CrossRefPubMedPubMedCentral Song F, Altman DG, Glenny AM, Deeks JJ: Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003, 326 (7387): 472-475. 10.1136/bmj.326.7387.472.CrossRefPubMedPubMedCentral
13.
go back to reference Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Glenny AM, Deeks JJ, et al: Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ. 2011, 343: d4909-10.1136/bmj.d4909.CrossRefPubMedPubMedCentral Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Glenny AM, Deeks JJ, et al: Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ. 2011, 343: d4909-10.1136/bmj.d4909.CrossRefPubMedPubMedCentral
14.
go back to reference Chou R, Fu R, Huffman LH, Korthuis PT: Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet. 2006, 368 (9546): 1503-1515. 10.1016/S0140-6736(06)69638-4.CrossRefPubMed Chou R, Fu R, Huffman LH, Korthuis PT: Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet. 2006, 368 (9546): 1503-1515. 10.1016/S0140-6736(06)69638-4.CrossRefPubMed
15.
go back to reference Madan J, Stevenson MD, Cooper KL, Ades AE, Whyte S, Akehurst R: Consistency between direct and indirect trial evidence: is direct evidence always more reliable?. Value Health. 2011, 14 (6): 953-960. 10.1016/j.jval.2011.05.042.CrossRefPubMed Madan J, Stevenson MD, Cooper KL, Ades AE, Whyte S, Akehurst R: Consistency between direct and indirect trial evidence: is direct evidence always more reliable?. Value Health. 2011, 14 (6): 953-960. 10.1016/j.jval.2011.05.042.CrossRefPubMed
16.
go back to reference Gartlehner G, Moore CG: Direct versus indirect comparisons: a summary of the evidence. Int J Technol Assess Health Care. 2008, 24 (2): 170-177.CrossRefPubMed Gartlehner G, Moore CG: Direct versus indirect comparisons: a summary of the evidence. Int J Technol Assess Health Care. 2008, 24 (2): 170-177.CrossRefPubMed
17.
go back to reference Dias S, Welton NJ, Caldwell DM, Ades AE: Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29 (7–8): 932-944.CrossRefPubMed Dias S, Welton NJ, Caldwell DM, Ades AE: Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29 (7–8): 932-944.CrossRefPubMed
18.
go back to reference Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ: Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med. 2009, 28 (14): 1861-1881. 10.1002/sim.3594.CrossRefPubMed Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ: Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Stat Med. 2009, 28 (14): 1861-1881. 10.1002/sim.3594.CrossRefPubMed
19.
go back to reference Salanti G, Marinho V, Higgins JP: A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009, 62 (8): 857-864. 10.1016/j.jclinepi.2008.10.001.CrossRefPubMed Salanti G, Marinho V, Higgins JP: A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009, 62 (8): 857-864. 10.1016/j.jclinepi.2008.10.001.CrossRefPubMed
20.
go back to reference Mills EJ, Ghement I, O'Regan C, Thorlund K: Estimating the power of indirect comparisons: a simulation study. PLoS One. 2011, 6 (1): e16237-10.1371/journal.pone.0016237.CrossRefPubMedPubMedCentral Mills EJ, Ghement I, O'Regan C, Thorlund K: Estimating the power of indirect comparisons: a simulation study. PLoS One. 2011, 6 (1): e16237-10.1371/journal.pone.0016237.CrossRefPubMedPubMedCentral
21.
go back to reference Wells GA, Sultan SA, Chen L, Khan M, Coyle D: Indirect evidence: indirect treatment comparisons in meta-analysis. 2009, Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health Wells GA, Sultan SA, Chen L, Khan M, Coyle D: Indirect evidence: indirect treatment comparisons in meta-analysis. 2009, Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health
22.
go back to reference DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clin Trials. 1986, 7: 177-188. 10.1016/0197-2456(86)90046-2.CrossRefPubMed
23.
go back to reference Salanti G, Higgins JP, Ades AE, Ioannidis JP: Evaluation of networks of randomized trials. Stat Methods Med Res. 2008, 17 (3): 279-301.CrossRefPubMed Salanti G, Higgins JP, Ades AE, Ioannidis JP: Evaluation of networks of randomized trials. Stat Methods Med Res. 2008, 17 (3): 279-301.CrossRefPubMed
24.
go back to reference Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE: NICE DSU Technical Support Document 4: Inconsistency in Network of Evidence Based on Randomised Controlled Trials. 2011, Available from http://www.nicedsu.org.uk Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE: NICE DSU Technical Support Document 4: Inconsistency in Network of Evidence Based on Randomised Controlled Trials. 2011, Available from http://​www.​nicedsu.​org.​uk
25.
go back to reference Eckermann S, Coory M, Willan AR: Indirect comparison: relative risk fallacies and odds solution. J Clin Epidemiol. 2009, 62 (10): 1031-1036. 10.1016/j.jclinepi.2008.10.013.CrossRefPubMed Eckermann S, Coory M, Willan AR: Indirect comparison: relative risk fallacies and odds solution. J Clin Epidemiol. 2009, 62 (10): 1031-1036. 10.1016/j.jclinepi.2008.10.013.CrossRefPubMed
26.
go back to reference Pullenayegum EM: An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes. Stat Med. 2011, 30 (26): 3082-3094. 10.1002/sim.4326.CrossRefPubMed Pullenayegum EM: An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes. Stat Med. 2011, 30 (26): 3082-3094. 10.1002/sim.4326.CrossRefPubMed
27.
go back to reference Higgins JP, Altman DG: Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins J, Green S. 2008, Chichester: WileyCrossRef Higgins JP, Altman DG: Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Edited by: Higgins J, Green S. 2008, Chichester: WileyCrossRef
28.
go back to reference R_Development_Core_Team: R: A language and environment for statistical computing. In. Vienna, Austria. 2008, Vienna, Austria: R Foundation for Statistical Computing R_Development_Core_Team: R: A language and environment for statistical computing. In. Vienna, Austria. 2008, Vienna, Austria: R Foundation for Statistical Computing
29.
go back to reference Song F, Harvey I, Lilford R: Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol. 2008, 61 (5): 455-463. 10.1016/j.jclinepi.2007.06.006.CrossRefPubMed Song F, Harvey I, Lilford R: Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol. 2008, 61 (5): 455-463. 10.1016/j.jclinepi.2007.06.006.CrossRefPubMed
30.
go back to reference Hardy RJ, Thompson SG: Detecting and describing heterogeneity in meta-analysis. Stat Med. 1998, 17 (8): 841-856. 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D.CrossRefPubMed Hardy RJ, Thompson SG: Detecting and describing heterogeneity in meta-analysis. Stat Med. 1998, 17 (8): 841-856. 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D.CrossRefPubMed
31.
go back to reference Nixon RM, Bansback N, Brennan A: Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med. 2007, 26 (6): 1237-1254. 10.1002/sim.2624.CrossRefPubMed Nixon RM, Bansback N, Brennan A: Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med. 2007, 26 (6): 1237-1254. 10.1002/sim.2624.CrossRefPubMed
32.
go back to reference Dias S, Welton NJ, Sutton AJ, Ades AE: NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. 2011, Available from: http://www.nicedsu.org.uk Dias S, Welton NJ, Sutton AJ, Ades AE: NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. 2011, Available from: http://​www.​nicedsu.​org.​uk
33.
go back to reference Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, Klassen TP: Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009, 339: b4012-10.1136/bmj.b4012.CrossRefPubMedPubMedCentral Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, Klassen TP: Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009, 339: b4012-10.1136/bmj.b4012.CrossRefPubMedPubMedCentral
34.
go back to reference Juni P, Altman DG, Egger M: Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001, 323 (7303): 42-46. 10.1136/bmj.323.7303.42.CrossRefPubMedPubMedCentral Juni P, Altman DG, Egger M: Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001, 323 (7303): 42-46. 10.1136/bmj.323.7303.42.CrossRefPubMedPubMedCentral
35.
go back to reference Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273 (5): 408-412.PubMed Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995, 273 (5): 408-412.PubMed
36.
go back to reference Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008, 336 (7644): 601-605. 10.1136/bmj.39465.451748.AD.CrossRefPubMedPubMedCentral Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008, 336 (7644): 601-605. 10.1136/bmj.39465.451748.AD.CrossRefPubMedPubMedCentral
37.
go back to reference Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S: Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ. 2012, 344: e1119-10.1136/bmj.e1119.CrossRefPubMed Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S: Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ. 2012, 344: e1119-10.1136/bmj.e1119.CrossRefPubMed
38.
go back to reference Chalmers I, Matthews R: What are the implications of optimism bias in clinical research?. Lancet. 2006, 367 (9509): 449-450. 10.1016/S0140-6736(06)68153-1.CrossRefPubMed Chalmers I, Matthews R: What are the implications of optimism bias in clinical research?. Lancet. 2006, 367 (9509): 449-450. 10.1016/S0140-6736(06)68153-1.CrossRefPubMed
39.
go back to reference Thompson S, Ekelund U, Jebb S, Lindroos AK, Mander A, Sharp S, Turner R, Wilks D: A proposed method of bias adjustment for meta-analyses of published observational studies. Int J Epidemiol. 2011, 40 (3): 765-777. 10.1093/ije/dyq248.CrossRefPubMed Thompson S, Ekelund U, Jebb S, Lindroos AK, Mander A, Sharp S, Turner R, Wilks D: A proposed method of bias adjustment for meta-analyses of published observational studies. Int J Epidemiol. 2011, 40 (3): 765-777. 10.1093/ije/dyq248.CrossRefPubMed
40.
go back to reference Turner RM, Spiegelhalter DJ, Smith GC, Thompson SG: Bias modelling in evidence synthesis. J R Stat Soc A. 2009, 172 (1): 21-47. 10.1111/j.1467-985X.2008.00547.x.CrossRef Turner RM, Spiegelhalter DJ, Smith GC, Thompson SG: Bias modelling in evidence synthesis. J R Stat Soc A. 2009, 172 (1): 21-47. 10.1111/j.1467-985X.2008.00547.x.CrossRef
41.
go back to reference Welton NJ, Ades AE, Carlin JB, Altman DG, Sterne JA: Models for potentially biased evidence in meta-analysis using empirically based priors. J R Stat Soc A. 2009, 172 (Part 1): 119-136.CrossRef Welton NJ, Ades AE, Carlin JB, Altman DG, Sterne JA: Models for potentially biased evidence in meta-analysis using empirically based priors. J R Stat Soc A. 2009, 172 (Part 1): 119-136.CrossRef
42.
go back to reference Xiong T, Parekh-Burke S, Loke YK, Abdelhamid A, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Walsh T, Glenny AM, et al: Assessment of trial similarity and evidence consistency for indirect treatment comparison: an empirical investigation. J Clin Epidemiol. 2012, In press Xiong T, Parekh-Burke S, Loke YK, Abdelhamid A, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Walsh T, Glenny AM, et al: Assessment of trial similarity and evidence consistency for indirect treatment comparison: an empirical investigation. J Clin Epidemiol. 2012, In press
Metadata
Title
Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons
Authors
Fujian Song
Allan Clark
Max O Bachmann
Jim Maas
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2012
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-12-138

Other articles of this Issue 1/2012

BMC Medical Research Methodology 1/2012 Go to the issue